Local biopharma Neurocrine Biosciences Inc. has filed an Investigational New Drug application with the U.S. Food and Drug Administration for its movement disorder drug, valbenazine.
Tijuana’s Manufacturing and S.D.’s Medical Cos.’ Interests Should Align, But Will They?
Cali Baja has become the world mecca of medical device manufacturing, and yet many companies — even here in San Diego — are choosing to do their manufacturing elsewhere.
La Jolla-based Viking Therapeutics has entered into a $12.5 million common stock purchase agreement with Aspire Capital Fund LLC, Viking announced Thursday.
Local startup accelerator, CONNECT, is partnering with DeskHub, one of San Diego’s biggest coworking spaces.
ECONOMY: Millennials, Changing Labor Market Make Work Perks a Must
It’s sad, but true: many workers feel disposable, and employers do little to discourage the feeling, according to market research.
San Diego drugmaker ACADIA Pharmaceuticals Inc. has appointed Todd Young as executive vice president and chief financial officer.
Shares of Sophiris Bio Inc. were tanking Tuesday on news of the company’s secondary stock offering.
San Diego’s business accelerator CONNECT is launching a new investor syndicate to help fund “disruptive” technology and life science startups in San Diego.
San Diego’s Fate Therapeutics has raised $10.3 million in an equity deal, according to a recent form filed with the Securities and Exchange Commission.
Ireland-based Zenith Technologies is opening a new site in San Diego to meet demand for its services on the West Coast.